BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2469045)

  • 1. Galanin-like immunoreactivity is present in human substantia innominata and in senile plaques in Alzheimer's disease.
    Kowall NW; Beal MF
    Neurosci Lett; 1989 Mar; 98(1):118-23. PubMed ID: 2469045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperinnervation of surviving neurons of the human basal nucleus of meynert by galanin in dementias of Alzheimer's and Parkinson's disease.
    Chan-Palay V
    Adv Neurol; 1990; 51():253-5. PubMed ID: 1688477
    [No Abstract]   [Full Text] [Related]  

  • 3. Peptidergic neurons in the basal forebrain magnocellular complex of the rhesus monkey.
    Walker LC; Koliatsos VE; Kitt CA; Richardson RT; Rökaeus A; Price DL
    J Comp Neurol; 1989 Feb; 280(2):272-82. PubMed ID: 2466877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
    Chan-Palay V
    J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex.
    Beal MF; Clevens RA; Chattha GK; MacGarvey UM; Mazurek MF; Gabriel SM
    J Neurochem; 1988 Dec; 51(6):1935-41. PubMed ID: 2460590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between cortical plaque count and neuronal loss in the nucleus basalis in Alzheimer's disease.
    Arendt T; Bigl V; Tennstedt A; Arendt A
    Neurosci Lett; 1984 Jul; 48(1):81-5. PubMed ID: 6472737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease.
    Beal MF; MacGarvey U; Swartz KJ
    Ann Neurol; 1990 Aug; 28(2):157-61. PubMed ID: 1699471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease.
    Rasool CG; Svendsen CN; Selkoe DJ
    Ann Neurol; 1986 Oct; 20(4):482-8. PubMed ID: 3539000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer's type: possible role in cell loss.
    Saper CB; German DC; White CL
    Neurology; 1985 Aug; 35(8):1089-95. PubMed ID: 4022341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calbindin-immunoreactive cholinergic neurones in the nucleus basalis of Meynert in Alzheimer-type dementia.
    Ichimiya Y; Emson PC; Mountjoy CQ; Lawson DE; Iizuka R
    Brain Res; 1989 Oct; 499(2):402-6. PubMed ID: 2804687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galanin-immunoreactivity in the nucleus basalis of Meynert in the rat: age-related changes and differential response to lesion-induced cholinergic cell loss.
    Unger JW; Schmidt Y
    Neurosci Lett; 1993 Apr; 153(2):140-3. PubMed ID: 7687047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease.
    Salehi A; Verhaagen J; Dijkhuizen PA; Swaab DF
    Neuroscience; 1996 Nov; 75(2):373-87. PubMed ID: 8931004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alzheimer's disease and Meynert's nucleus basalis. An anatomo- clinical point of view].
    Brion S; Plas J; Massé G
    Encephale; 1986; 12(3):111-4. PubMed ID: 3769856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galanin immunoreactivity in the primate central nervous system.
    Kordower JH; Le HK; Mufson EJ
    J Comp Neurol; 1992 May; 319(4):479-500. PubMed ID: 1377713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plaque-like lesions in the basal forebrain in Alzheimer's disease.
    Jacobs RW; Farivar N; Butcher LL
    Neurosci Lett; 1985 May; 56(3):347-51. PubMed ID: 2410820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid deposition in the nucleus basalis of Meynert complex: a topographic marker for degenerating cell clusters in Alzheimer's disease.
    Arendt T; Taubert G; Bigl V; Arendt A
    Acta Neuropathol; 1988; 75(3):226-32. PubMed ID: 3348080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Abnormalities of neurotransmitters in Alzheimer's disease. Disturbance of the acetylcholine system and nucleus basalis of Meynert].
    Arai H; Iizuka R
    Nihon Rinsho; 1988 Jul; 46(7):1491-5. PubMed ID: 3221455
    [No Abstract]   [Full Text] [Related]  

  • 18. Distribution of beta-nerve growth factor receptors in the human basal forebrain.
    Allen SJ; Dawbarn D; Spillantini MG; Goedert M; Wilcock GK; Moss TH; Semenenko FM
    J Comp Neurol; 1989 Nov; 289(4):626-40. PubMed ID: 2556457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galanin-like immunoreactivity within the primate basal forebrain: differential staining patterns between humans and monkeys.
    Kordower JH; Mufson EJ
    J Comp Neurol; 1990 Apr; 294(2):281-92. PubMed ID: 1692044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between senile plaque and neurofibrillary tangle counts in cerebral cortex and neuronal counts in cortex and subcortical structures in Alzheimer's disease.
    Mann DM; Yates PO; Marcyniuk B
    Neurosci Lett; 1985 May; 56(1):51-5. PubMed ID: 4011048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.